Abstract:The human UBR5 (also known as EDD) is a single polypeptide chain HECT-type E3 ubiquitin ligase essential for embryonic development in mammals. Although widely expressed, UBR5 is markedly amplified and overexpressed in breast, ovarian, prostate, gastric and pancreatic cancers. Dysregulated UBR5 functions like an oncoprotein to promote cancer growth and metastasis, making UBR5 a potential target for therapeutics. Unexpectedly, we found that human UBR5 assembles a dimer and a tetramer in solution. We determined the dimer structure at 2.8 [A] and the tetramer structure at 3.5 [A] average resolution. UBR5 is a crescent shaped molecule with a seven-bladed {beta}-propeller and two small {beta}-barrel domains (SBB1/2) at the N-terminal region, a catalytic HECT domain at the C-terminus, and an extended helical scaffold and an N-degron-recognizing UBR box in the middle. The dimer is assembled as a stable head-to-tail dimer via extensive interactions in the middle helical scaffold region. The tetramer is assembled via SBB2-SBB2 interaction from two face-to-face dimers, forming a large cage with all four catalytic HECT domains facing the central cavity. Importantly, the N-terminal region of one subunit and the HECT of the other form an intermolecular jaw in the dimer. Using enzymatic and cellular assays, we showed that the jaw-lining residues are important for function, suggesting that the intermolar jaw functions to recruit ubiquitin loaded E2 to UBR5 for the transthiolation reaction. Further work is needed to understand how oligomerization regulates the UBR5 ligase activity. This work provides a framework for structure-based anticancer drug development against the distinctive HECT E3 ligase and contributes to a growing appreciation of E3 ligase diversity.

Structure of the human UBR5 E3 ubiquitin ligase

Cryo-EM structure of the chain-elongating E3 ligase UBR5

UBE2A and UBE2B are recruited by an atypical E3 ligase module in UBR4

A review: targeting UBR5 domains to mediate emerging roles and mechanisms - chance or necessity?

Crystal structure of the catalytic C‐lobe of the HECT‐type ubiquitin ligase E6AP

The role of UBR5 in tumor proliferation and oncotherapy

UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer

Noncanonical assembly, neddylation and chimeric cullin–RING/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex

Structural Insights Into the Initiation and Elongation of Ubiquitination by Ubr1

Structural insights into the ubiquitylation strategy of the oligomeric CRL2FEM1B E3 ubiquitin ligase

Cryo-EM structure of the KLHL22 E3 ligase bound to an oligomeric metabolic enzyme

HUWE1 employs a giant substrate-binding ring to feed and regulate its HECT E3 domain

A Tunable Brake for HECT Ubiquitin Ligases.

Structural mechanisms of autoinhibition and substrate recognition by the ubiquitin ligase HACE1

Structural insights into Ubr1-mediated N-degron polyubiquitination

Structural Visualization of HECT-E3 Ufd4 accepting and transferring Ubiquitin to Form K29/K48-branched Polyubiquitination on N-degron

A structurally unique E2-binding domain activates ubiquitination by the ERAD E2, Ubc7p, through multiple mechanisms.

The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders

Structural study of UFL1-UFC1 interaction uncovers the role of UFL1 N-terminal helix in ufmylation

The E3 ligase HUWE1 interacts with ubiquitin non‐covalently via key residues in the HECT domain

The unifying catalytic mechanism of the RING-between-RING E3 ubiquitin ligase family